In memoriam: Isao Yamazaki

Yamazaki was born September 1, 1924 in Otaru City, Hokkaido, Japan. He obtained his bachelor's degree in 1948 at Hokkaido University and his doctorate in 1958. His graduate research focused on peroxidase reactions.
After serving for two years on the faculty at Tohoku University, Yamazaki pursued a postdoctoral fellowship in 1959 in the department of biochemistry at the University of Oregon Medical School where he began his work on free radicals with Howard Mason. He returned to Japan and to Tohoku University in 1961, and he served concurrently in the Applied Electrical Research Laboratory at Hokkaido University. He pursued groundbreaking research on enzyme reactions, electrons and reactive oxygen species for 34 years.
Yamazaki’s work on free radicals was honored and highlighted in a 2010 Journal of Biological Chemistry Classics article by Robert Hill, a longtime biochemistry faculty member at Duke University.
Hill and his coauthors wrote that both papers covered in the Classics article “not only demonstrated the excellent correlation of the free radical signals with the proposed reaction kinetics but also confirmed Leonor Michaelis' theory that the two-step oxidation of organic compounds involves a chemical radical.”
After retiring from Hokkaido University in 1988, Yamazaki became a visiting professor at Utah State University, Logan, where he continued to do research.
Yamazaki received many honors including being elected an honorary member of the American Society of Biological Chemists in 1983. After his scientific career, he pursued Buddhism research and published a book titled “The Origin of Buddhism, Its Wisdom and Faith.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.